Chronic Diabetic Foot Ulcers Clinical Trial
Official title:
Evaluation of Electrical Auricular Vagal Nerve Stimulation Effects on Parameters of Wound Healing in Chronic Diabetic Wounds - Pilot Study
Verified date | March 2017 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this pilot study is to evaluate the effect of auricular autonomous nervous system stimulation on vital parameters of wound healing in diabetics. It is investigated if auricular vagal nerve stimulation has an effect on heart rate variability as well as peripheral local blood perfusion, and if this effect depends on the health status of the study participants (diseased/healthy).
Status | Completed |
Enrollment | 24 |
Est. completion date | April 13, 2015 |
Est. primary completion date | April 13, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - diabetes mellitus type 2 - ulcus cruris (plantar) - min. 6 weeks of standard wound therapy without success - intact big toe on wound side Exclusion Criteria: - participation in a clinical trial in the last 5 weeks - confounding medical treatment, e.g. prostaglandin - vascular diseases other than peripheral arterial occlusive disease - diseases which may affect the autonomous nervous system or wound healing, except diabetic concomitant diseases (e.g., polyneuropathy, angiopathy) - drug abuse - active implanted devices - pregnancy or nursing |
Country | Name | City | State |
---|---|---|---|
Austria | University Clinic for Surgery, Department of Transplantation, Medical University Vienna | Vienna |
Lead Sponsor | Collaborator |
---|---|
Medical University of Vienna | Vienna University of Technology |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in heart rate variability (HRV) related to physiological state (diabetics/healthy) | Heart rate variability will be assessed as, e.g., standard deviation in heart rate over a time window of 5 minutes (30 seconds overlap). Changes in mean value and standard deviation of heart rate variability between healthy and diabetic patients will be assessed using statistical tests. |
within 4 days of intervention | |
Primary | change in local blood perfusion index (BPI) related to physiological state (diabetics/healthy) | Blood perfusion index at the foot will be assessed as peak-peak amplitude (systolic to diastolic) divided by the mean signal value of optically measured blood perfusion. Changes in mean value and standard deviation of local blood perfusion index between healthy and diabetic patients will be assessed using statistical tests. |
within 4 days of intervention | |
Secondary | Change in HRV and local BPI due to distinct stimulation patterns | Two distinct stimulation patterns are tested during intervention. Changes in mean value and standard deviation of HRV/BPI due to these stimulation patterns will be assessed using statistical tests. |
within 4 days of intervention | |
Secondary | Change of local BPI in upper and lower extremities | Local BPI is assessed using optical sensors on the foot and the finger of participants. Changes in mean value of BPI are analyzed using statistical tests. |
within 4 days of intervention | |
Secondary | Changes in blood pressure | Blood pressure is continuously measured using inflatable finger cuffs. | within 4 days of intervention | |
Secondary | Changes in respiratory activity | Respiratory activity is monitored using a respiratory belt. | within 4 days of intervention | |
Secondary | Changes in oxygen saturation of the toe and wound | within 4 days of intervention | ||
Secondary | Changes in partial transcutaneous oxygen pressure of the wound region | within 4 days of intervention | ||
Secondary | Changes in foot skin temperature | within 4 days of intervention | ||
Secondary | Changes of C reactive protein- and leukocyte-concentration in serum | within 4 days of intervention | ||
Secondary | Tolerance of stimulation | Tolerance of stimulation is assessed by survey. | within 4 days of intervention | |
Secondary | Perception of Stimulation | Perception of stimulation is assessed by survey. | within 4 days of intervention | |
Secondary | Adverse effects of stimulation | within 4 days of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04457752 -
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
|
Phase 4 | |
Terminated |
NCT02571738 -
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
|
Phase 3 | |
Completed |
NCT00632008 -
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
|
Phase 3 | |
Recruiting |
NCT00366132 -
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
|
Phase 2 | |
Terminated |
NCT05276401 -
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
|
Phase 2 | |
Completed |
NCT03282981 -
Beta Adrenergic Antagonist for the Healing of Chronic DFU
|
Phase 3 | |
Withdrawn |
NCT00954343 -
Shockwave Treatment of Diabetic Foot Ulcer: Step I
|
N/A | |
Recruiting |
NCT04962139 -
Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
|
Phase 3 |